NCT06205030CompletedPhase 4
Efficacy of NOSHINtrial in Diabetic Patients
Efficacy of a Traditional Anti-diabetic Herbal Drug on Glycemic, Inflammatory, and Oxidative Stress Parameters in Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
The goal of this \[Efficacy of a traditional anti-diabetic herbal drug with on glycemic, inflammatory, and oxidative stress parameters\] is \[investigate the level of HOMA-estimated insulin resistance as the primary outcome before and after 40 days in intervention and placebo groups\] in \[patients with type 2 diabetes\]. The secondary outcomes of this study are the assessment of oxidative stress, inflammation biomarkers, other glycemic indices, hematopoietic status and lipid profile between the two groups before and after the intervention. also The food frequency questionnaire (FFQ) and the physical activity questionnaire (FAQ) are used to evaluate the effect of potential confounding factors. This study has the code of ethics IR.KMU.REC.1402.291 from Kerman University of Medical Sciences and this drug has the number 12/14484 from Iran Food and Drug Administration (IFDA).
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 19 Dec 2023
- Start date
- 26 Sept 2025
- Primary completion date
- 16 Jul 2026
- Lead sponsor
- Kerman Medical University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06205030
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 70
- From 26 Sept 2025 to the primary completion date, 16 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking anti-inflammatory drugs such as aspirin with an anti-inflammatory dose, antioxidant supplements, vitamins and omega-3 capsules (\<1 g/day), and immunosuppressive drugs in the last three months.
Other illness
- Performing CABG surgery, occurrence of ASC, heart and brain stroke, pulmonary embolism, deep vein thrombosis or TIA in the last 1 year.
- Presence of cancer, liver and thyroid diseases.
Other
- pregnancy
- Smoking and alcohol consumption
Who the study is looking for
- Age between 20 and 65 years
- HbA1c more than 6.5
- Consistency of diet and exercise program
- Body mass index less than 35
- Not receiving insulin
- The patient should take standard medicine except insulin
Age in the registry: 20 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kerman University of Medical Sciences Coordinator of this site? Confirm its status | Kerman | Iran | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.